World-first breakthrough for Thalassaemia

In a world first, Royal Prince Alfred Hospital clinicians are among an international team to have found a gene therapy cure for Thalassaemia, a condition where sufferers must undergo regular blood transfusions and treatments for iron-overload, for life. Thalassaemia...

Car-T Therapy trials to get $2m Cancer Council funding

Cure The Future are proud to announce that Prof John Rasko and his team at the Centenary Institute at Royal Prince Alfred Hospital in Sydney are to receive a major grant from the Cancer Council to help fund the new CAR-T therapy trials, which are also a focus of our...

Haemophilia Breakthrough

World-First Breakthrough treatment for Haemophilia Cure The Future is proud to have supported researchers at Royal Prince Alfred Hospital as part of an international team who have developed a gene therapy for the life-threatening blood disorder, haemophilia. The...

FDA Approves 2nd Car-T Therapy – for Adult Lymphoma

On October 18th, the U.S. Food and Drug Administration approved another cell-based gene therapy, to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other kinds of treatment....

Cure The Future helps 1st time gene discovery

First-time discovery of a common pattern in gene regulation could provide clues for new treatments for cancer and other diseases. Dr Ulf Schmitz and Centenary Institute’s Gene & Stem Cell Therapy Program, led by Professor John Rasko AO, have – for the first time –...